GRAL peer analysis
GRAIL (GRAL) against its competitors: price, today's move, 1-year return and market value side by side.
GRAL and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| BLLN BillionToOne | $115.26 | 2.55% | – | – |
| BNR Burning Rock | $13.25 | 3.27% | 17.15% | $116.78M |
| CSTL Castle Biosciences | $32.52 | -4.91% | -3.13% | $993.47M |
| FLGT Fulgent Genetics | $23.50 | 25.94% | 3.16% | $646.61M |
| GH Guardant Health | $150.00 | -2.24% | 57.81% | $20.13B |
| MYGN Myriad Genetics | $5.90 | -6.20% | -10.33% | $564.33M |
| NEO NeoGenomics | $16.84 | 2.12% | 61.46% | $2.18B |
| NTRA Natera | $311.20 | -14.45% | 55.66% | $44.86B |
| PSNL Personalis | $15.79 | 1.54% | 106.14% | $1.65B |
| WGS GeneDx | $62.75 | -2.50% | -54.15% | $1.87B |
| GRAL GRAIL | $122.47 | 2.80% | 51.78% | – |
- GRAL's peers: BLLN (BillionToOne), BNR (Burning Rock), CSTL (Castle Biosciences), FLGT (Fulgent Genetics), GH (Guardant Health), MYGN (Myriad Genetics), NEO (NeoGenomics), NTRA (Natera).
Updated 2026-11-07 11:54 UTC